Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

Clinical trial NCT01187550 · COMPLETED

Trial details

NCT number: NCT01187550
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dwarfism, Pituitary

Start date: 2007-03-01
Primary completion: 2008-09-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.